Nepal | May 30, 2020

DDA lacks equipment to test impurity in prescription drug Ranitidine

Sabitri Dhakal
Share Now:

Kathmandu, October 15

Though the Department of Drug Administration, Nepal’s drug regulatory authority, has directed all pharmaceutical manufacturers and suppliers to avoid N-nitrosodimethylamine impurity in ranitidine, the department itself doesn’t have equipment to conduct the necessary tests. Randitidine is used to treat ulcers of the stomach and intestines.

International Agency for Research on Cancer has classified N-nitrosodimethylamine impurity as carcinogenic to humans. US Food and Drug Administration has recommended Liquid Chromatography-High Resolution Mass Spectrometry  testing protocol to test samples of ranitidine. LC-HRMS is a method used to determine impurities in drugs.

“We don’t have equipment for the test,” said Pan Bahadur Chhetri, acting director at the Department of Drugs. “However, to ensure patient’s safety, we have told all pharmaceutical manufacturers and suppliers to avoid N-nitrosodimethylamine impurity in raw materials, manufactured medicines and supply of ranitidine. We can ask for analysis reports of the raw materials and manufactured medicines from suppliers,” Chhetri added.

Releasing a statement, the US Food and Drug Administration had said some ranitidine medicines, contained a nitrosamine impurity called N-nitrosodimethylamine at low levels. N-nitrosodimethylamine has been classified as a substance that could cause cancer, based on results from laboratory tests. N-nitrosodimethylamine is a known environmental contaminant and is found in water and food, including meats, dairy products, and vegetables.

Ranitidine is a commonly prescribed medicine for countering acidity and is on World Health Organisation’s Model List of Essential Medicines.

Ranitidine is an over-the-counter and prescription drug. Ranitidine is an H2 (histamine-2) blocker, which decreases the amount of acid created by the stomach. Over-the-counter ranitidine has been approved to prevent and relieve heartburn associated with acid ingestion and sour stomach. Prescription ranitidine is approved for multiple indications, including treatment and prevention of ulcers of the stomach and intestines and treatment of gastroesophageal reflux disease, according to the US Food and Drug Administration.

The national drug regulatory authority does not have records of how many versions of the drug are been sold in the Nepali market.


A version of this article appears in print on October 16, 2019 of The Himalayan Times.

Follow The Himalayan Times on Twitter and Facebook

Recommended Stories:

More from The Himalayan Times:

Are we doing enough for the mental health of healthcare workers?

The number of coronavirus patients has been increasing over the past few days in Nepal. In the current scenario, it seems like the numbers would further increase in the coming days. Given that healthcare workers and frontline staff are the first responders to manage the ongoing pandemic with limited Read More...

With a gay protagonist, Pixar short ‘Out’ makes history

NEW YORK: In Steven Clay Hunter’s 23 years as an animator at Pixar, he has drawn a seven-armed octopus, a Canadian daredevil and a wheezing toy penguin. But there were scenes he never expected to animate until he began working on his short, “Out.” Hunter wrote and directed the nine-minute Pi Read More...

Heavy discount on income tax for small businesses

KATHMANDU, MAY 28 Announcing the federal budget for fiscal year 2020-21, Finance Minister Yubaraj Khatiwada has offered heavy income tax exemption to small and cottage industrialists. The government has exempted income tax of up to 75 per cent for businesses with annual transactions of up to R Read More...

In Pictures: Sithi Nakha in Lalitpur

People clean the traditional stone taps and pond to mark the "Sithi Nakha" festival, in Lalitpur, on Thursday, May 28, 2020. The Newar community celebrate Sithi Nakha to mark the beginning of monsoon season by cleaning water sources such as ponds, wells, and stone spouts. Photo: Naresh Shrestha/ Read More...


Three dengue patients identified in Tanahun

TANAHUN: As many as three patients of dengue have been identified at GP Koirala National Centre For Respiratory Diseases in Shuklagandaki Municipality, Tanahun. According to Chief of the Centre, Dr Ram Kumar Shrestha, two of the three patients are receiving treatment there while the third patient Read More...

 Hong Kong govt warns removing US special status is 'double-edged sword'

Hong Kong tells Washington to stay out of its affairs Trump expected to make China announcement later Friday China security ministry to "guide" Hong Kong police HONG KONG: Hong Kong told the United States to keep out of the internal debate over new national security laws being imposed b Read More...

Worldwide coronavirus cases cross 5.82 million, death toll tops 359,000

More than 5.82 million people have been reported infected with the novel coronavirus globally and 359,389 have died, a Reuters tally shows. Infections have been reported in more than 210 countries and territories since the first cases were identified in China in December 2019. New York Mayor B Read More...

Government cuts sports budget heavily

KATHMANDU, MAY 28 The government slashed the sports budget for the upcoming fiscal year heavily although it reiterated the overall development of the sector. Presenting the fiscal budget of 2020-21 at the joint meeting of House of Representatives and the National Assembly, Finance Minister Yub Read More...